Guangzhou GET Venture Capital

Overview

Guangzhou GET Venture Capital is a venture capital firm based in Guangzhou, China, specializing in investments within the biopharmaceutical industry. As a subsidiary of Guangzhou High-Tech Investment Group, the firm manages capital exceeding RMB 3 billion, primarily focusing on the biopharmaceutical sector. The firm has invested in over 100 companies, including Guangzhou Leader Biological Technology Co. Ltd., Surexam Biotechnology Co. Ltd., Guangzhou Hexin Instrument Co., Ltd., Smartspyeye Technologies, Inc., Shenzhen HuiHao Information Technology Co., Ltd., and Xiangxue Pharmaceutical Co., Ltd. As of June 30, 2022, GET Venture Capital managed funds totaling RMB 7.155 billion, with approximately RMB 1.137 billion invested in cutting-edge technology and biomedical firms. The firm employs complex metrics to carefully select its portfolio companies, aiming to establish a strong portfolio of small- and medium-sized technology firms. The overall return rate of GET Venture Capital's fund investments exceeded 128.14% as of June 30, 2022. The firm has also engaged in joint ventures, such as the $300 million partnership with BeiGene to build a commercial-scale biologics manufacturing facility in Guangzhou, Guangdong Province, China. This joint venture, BeiGene Biologics, aims to support the development of biologic drugs in China. The project is expected to break ground in the near future. Additionally, GET Venture Capital has invested in various funds, including the Guangdong Zhongkebaiyun Fund, Guangzhou Liding Fund, Guangzhou Lidinghengyi Fund, Guangzhou Detong Kaide Fund, and Lingkang Biology Fund, among others. These investments reflect the firm's commitment to fostering innovation and supporting the growth of technology and biomedical companies in the region. The firm's strategic focus on the biopharmaceutical industry aligns with Guangzhou's status as a hub for technological innovation and advanced manufacturing, particularly in the Greater Bay Area. The district has attracted significant investments and is home to numerous industry leaders, contributing to a robust ecosystem in smart vehicles, intelligent manufacturing, and green energy. Guangzhou GET Venture Capital's investments and partnerships play a pivotal role in advancing the biopharmaceutical sector and supporting the broader economic development of the region. The firm's investment strategy emphasizes the establishment of a strong portfolio of small- and medium-sized technology firms, with a particular focus on the biopharmaceutical industry. By managing a diverse range of funds and engaging in strategic partnerships, GET Venture Capital aims to foster innovation and support the growth of cutting-edge technology and biomedical companies. The firm's approach includes careful selection of portfolio companies using complex metrics, ensuring alignment with its investment objectives and the broader economic development goals of Guangzhou. Through its investments and partnerships, GET Venture Capital contributes to the advancement of the biopharmaceutical sector and the overall economic growth of the region. Guangzhou GET Venture Capital's strategic focus on the biopharmaceutical industry aligns with Guangzhou's status as a hub for technological innovation and advanced manufacturing, particularly in the Greater Bay Area. The district has attracted significant investments and is home to numerous industry leaders, contributing to a robust ecosystem in smart vehicles, intelligent manufacturing, and green energy. The firm's investments and partnerships play a pivotal role in advancing the biopharmaceutical sector and supporting the broader economic development of the region. The firm's investment strategy emphasizes the establishment of a strong portfolio of small- and medium-sized technology firms, with a particular focus on the biopharmaceutical industry. By managing a diverse range of funds and engaging in strategic partnerships, GET Venture Capital aims to foster innovation

Investment Focus

• Focus on biopharmaceutical industry
• Preference for small- and medium-sized technology firms
• Alignment with Guangzhou's economic development goals

Portfolio Companies